D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 46 Citations 8,915 92 World Ranking 3556 National Ranking 1620

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Immune system
  • Antibody

His scientific interests lie mostly in Systemic lupus erythematosus, Lupus nephritis, Immunology, Autoantibody and Lupus erythematosus. His Systemic lupus erythematosus study incorporates themes from Epitope and T cell. Syamal K. Datta interconnects Kidney, T-cell receptor, Fibrosis, Antibody and Nephritis in the investigation of issues within Lupus nephritis.

His research on Immunology often connects related areas such as Hamster. His Autoantibody research incorporates themes from Molecular biology and CD40. His work in Molecular biology tackles topics such as Antigen which are related to areas like Mesangium.

His most cited work include:

  • Nucleosome: A major immunogen for pathogenic autoantibody-inducing T cells of lupus (577 citations)
  • Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. (484 citations)
  • INTERACTION BETWEEN CD40 AND ITS LIGAND GP39 IN THE DEVELOPMENT OF MURINE LUPUS NEPHRITIS (383 citations)

What are the main themes of his work throughout his whole career to date?

Syamal K. Datta mainly investigates Immunology, Systemic lupus erythematosus, Autoantibody, Lupus erythematosus and Molecular biology. His research on Immunology frequently connects to adjacent areas such as CD40. His Systemic lupus erythematosus research incorporates elements of Cytotoxic T cell, B cell, Epitope, Lupus nephritis and Histone.

In his study, which falls under the umbrella issue of Lupus nephritis, Glomerulonephritis is strongly linked to Nephritis. Syamal K. Datta interconnects T cell, T-cell receptor, T lymphocyte and Immunoglobulin G in the investigation of issues within Autoantibody. His research integrates issues of Immune complex and Immunopathology in his study of Lupus erythematosus.

He most often published in these fields:

  • Immunology (68.57%)
  • Systemic lupus erythematosus (42.86%)
  • Autoantibody (41.90%)

What were the highlights of his more recent work (between 2003-2021)?

  • Immunology (68.57%)
  • Systemic lupus erythematosus (42.86%)
  • Autoimmunity (24.76%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Immunology, Systemic lupus erythematosus, Autoimmunity, IL-2 receptor and Cell biology. His study in Epitope, Autoantibody, Lupus erythematosus, Immune system and Antigen-presenting cell falls under the purview of Immunology. His research in Lupus erythematosus intersects with topics in Hematopoietic stem cell transplantation, Autoimmune disease and Rituximab.

His work carried out in the field of Systemic lupus erythematosus brings together such families of science as Cytotoxic T cell, Low dose, Antigen, Lupus nephritis and Histone. His Cell biology study integrates concerns from other disciplines, such as T cell, MHC class II, T-cell receptor, Apoptosis and Transformation. Syamal K. Datta works mostly in the field of ZAP70, limiting it down to concerns involving Programmed cell death and, occasionally, Molecular biology.

Between 2003 and 2021, his most popular works were:

  • Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory Th17 cells. (170 citations)
  • Very Low-Dose Tolerance with Nucleosomal Peptides Controls Lupus and Induces Potent Regulatory T Cell Subsets (165 citations)
  • Regulatory T Cell (Treg) Subsets Return in Patients with Refractory Lupus following Stem Cell Transplantation, and TGF-β-Producing CD8+ Treg Cells Are Associated with Immunological Remission of Lupus (129 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Immune system
  • Antibody

His primary areas of investigation include Systemic lupus erythematosus, Immunology, Immune system, Lupus erythematosus and CD8. His biological study spans a wide range of topics, including Cytotoxic T cell, Autoimmunity, ZAP70 and Programmed cell death. His Cytotoxic T cell research incorporates themes from Fas ligand, Autoantibody, Apoptosis and Molecular biology.

His research investigates the connection between Immune system and topics such as Lupus nephritis that intersect with issues in Antigen presentation, Antigen, Antigen-presenting cell and Cancer research. His Lupus erythematosus study frequently involves adjacent topics like Autoimmune disease. His CD8 research integrates issues from Epitope, Regulatory T cell, IL-2 receptor and Adoptive cell transfer.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production.

Ami Desai-Mehta;Liangjun Lu;Rosalind Ramsey-Goldman;Syamal K. Datta.
Journal of Clinical Investigation (1996)

765 Citations

Nucleosome: A major immunogen for pathogenic autoantibody-inducing T cells of lupus

Chandra Mohan;Sharlene Adams;Valerie Stanik;Syamal K. Datta.
Journal of Experimental Medicine (1993)

721 Citations

T cell receptor alpha/beta expressing double-negative (CD4-/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis.

S Shivakumar;G C Tsokos;S K Datta.
Journal of Immunology (1989)

536 Citations

INTERACTION BETWEEN CD40 AND ITS LIGAND GP39 IN THE DEVELOPMENT OF MURINE LUPUS NEPHRITIS

C. Mohan;Y. Shi;J. D. Laman;Syamal Kumar Datta.
Journal of Immunology (1995)

423 Citations

Induction of a cationic shift in IgG anti-DNA autoantibodies. Role of T helper cells with classical and novel phenotypes in three murine models of lupus nephritis.

S K Datta;H Patel;D Berry.
Journal of Experimental Medicine (1987)

316 Citations

Anti-CD40 Ligand Antibody Treatment of SNF1 Mice with Established Nephritis: Preservation of Kidney Function

Susan L. Kalled;Anne H. Cutler;Syamal K. Datta;David W. Thomas.
Journal of Immunology (1998)

305 Citations

Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory Th17 cells.

Hee Kap Kang;Michael Liu;Syamal K. Datta.
Journal of Immunology (2007)

267 Citations

Very Low-Dose Tolerance with Nucleosomal Peptides Controls Lupus and Induces Potent Regulatory T Cell Subsets

Hee Kap Kang;Marissa A. Michaels;Beate R. Berner;Syamal K. Datta.
Journal of Immunology (2005)

257 Citations

Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites.

Demetrios V. Vlahakos;Mary H. Foster;Sharlene Adams;Michael Katz.
Kidney International (1992)

252 Citations

Major peptide autoepitopes for nucleosome-specific T cells of human lupus

Liangjun Lu;Arunan Kaliyaperumal;Dimitrios T. Boumpas;Syamal K. Datta.
Journal of Clinical Investigation (1999)

241 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Syamal K. Datta

George C. Tsokos

George C. Tsokos

Harvard Medical School

Publications: 93

Sylviane Muller

Sylviane Muller

University of Strasbourg

Publications: 46

Bevra H. Hahn

Bevra H. Hahn

University of California, Los Angeles

Publications: 45

Michael P. Madaio

Michael P. Madaio

Augusta University

Publications: 42

Chandra Mohan

Chandra Mohan

University of Houston

Publications: 41

David A. Isenberg

David A. Isenberg

University College London

Publications: 40

Yehuda Shoenfeld

Yehuda Shoenfeld

Sheba Medical Center

Publications: 36

Ole Petter Rekvig

Ole Petter Rekvig

University of Tromsø - The Arctic University of Norway

Publications: 35

Argyrios N. Theofilopoulos

Argyrios N. Theofilopoulos

Scripps Research Institute

Publications: 32

David S. Pisetsky

David S. Pisetsky

Duke University

Publications: 32

Robert S. Schwartz

Robert S. Schwartz

University of Colorado Anschutz Medical Campus

Publications: 32

Edna Mozes

Edna Mozes

Weizmann Institute of Science

Publications: 29

Betty Diamond

Betty Diamond

Feinstein Institute for Medical Research

Publications: 29

Alfred D. Steinberg

Alfred D. Steinberg

Mitre (United States)

Publications: 28

Laurence Morel

Laurence Morel

The University of Texas Health Science Center at San Antonio

Publications: 28

Edward K. Wakeland

Edward K. Wakeland

The University of Texas Southwestern Medical Center

Publications: 25

Trending Scientists

Kamal Saggi

Kamal Saggi

Vanderbilt University

Todd Otanicar

Todd Otanicar

Boise State University

Andrea Facchinetti

Andrea Facchinetti

University of Padua

Thomas T. C. Hsu

Thomas T. C. Hsu

University of Houston

Keith Man-Chung Wong

Keith Man-Chung Wong

Southern University of Science and Technology

Xinhai Li

Xinhai Li

Central South University

Larry L. Tieszen

Larry L. Tieszen

United States Geological Survey

Thomas W. Boutton

Thomas W. Boutton

Texas A&M University

Richard A. Shakesby

Richard A. Shakesby

Swansea University

Norman Delanty

Norman Delanty

Beaumont Hospital

Julio Artieda

Julio Artieda

University of Navarra

Louis R. Kavoussi

Louis R. Kavoussi

Northwell Health

Howard Bergman

Howard Bergman

McGill University

Mijna Hadders-Algra

Mijna Hadders-Algra

University Medical Center Groningen

Richard D. Gelber

Richard D. Gelber

Harvard University

Robert L. Hanson

Robert L. Hanson

National Institutes of Health

Something went wrong. Please try again later.